These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28259862)

  • 1. [Modeling neurological and psychiatric disorders in vitro using induced pluripotent stem cells: highlighting findings in Alzheimer's disease and schizophrenia].
    Hathy E; Kalman S; Apati A; Nemoda Z; Rethelyi JM
    Neuropsychopharmacol Hung; 2016 Dec; 18(4):188-198. PubMed ID: 28259862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells.
    van Hugte E; Nadif Kasri N
    Adv Exp Med Biol; 2019; 1192():297-312. PubMed ID: 31705501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced Pluripotent Stem Cell Technology: A Paradigm Shift in Medical Science for Drug Screening and Disease Modeling.
    Nair M; Sandhu SS; Sharma AK
    Curr Med Chem; 2017; 24(39):4368-4398. PubMed ID: 28748763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent approaches and challenges in iPSCs: modeling and cell-based therapy of Alzheimer's disease.
    Csöbönyeiová M; Polák Š; Danišovič L
    Rev Neurosci; 2016 Jul; 27(5):457-64. PubMed ID: 26812864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling human neurological disorders with induced pluripotent stem cells.
    Imaizumi Y; Okano H
    J Neurochem; 2014 May; 129(3):388-99. PubMed ID: 24286589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human induced pluripotent stem cells as a research tool in Alzheimer's disease.
    Robbins JP; Price J
    Psychol Med; 2017 Nov; 47(15):2587-2592. PubMed ID: 28805182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of GABA-ergic cell therapy for schizophrenia, neuropathic pain, and Alzheimer's and Parkinson's diseases.
    Shetty AK; Bates A
    Brain Res; 2016 May; 1638(Pt A):74-87. PubMed ID: 26423935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease.
    Marei HE; Khan MUA; Hasan A
    Cell Mol Biol Lett; 2023 Nov; 28(1):98. PubMed ID: 38031028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling neurodevelopmental and psychiatric diseases with human iPSCs.
    Wen Z
    J Neurosci Res; 2017 May; 95(5):1097-1109. PubMed ID: 28186671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
    Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
    Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling Psychiatric Disorder Biology with Stem Cells.
    Das D; Feuer K; Wahbeh M; Avramopoulos D
    Curr Psychiatry Rep; 2020 Apr; 22(5):24. PubMed ID: 32318888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling neurological diseases with induced pluripotent cells reprogrammed from immortalized lymphoblastoid cell lines.
    Fujimori K; Tezuka T; Ishiura H; Mitsui J; Doi K; Yoshimura J; Tada H; Matsumoto T; Isoda M; Hashimoto R; Hattori N; Takahashi T; Morishita S; Tsuji S; Akamatsu W; Okano H
    Mol Brain; 2016 Oct; 9(1):88. PubMed ID: 27716287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell-derived neurons in the development of targeted treatment for schizophrenia and bipolar disorder.
    Watmuff B; Liu B; Karmacharya R
    Pharmacogenomics; 2017 Apr; 18(5):471-479. PubMed ID: 28346060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease signatures for schizophrenia and bipolar disorder using patient-derived induced pluripotent stem cells.
    Watmuff B; Berkovitch SS; Huang JH; Iaconelli J; Toffel S; Karmacharya R
    Mol Cell Neurosci; 2016 Jun; 73():96-103. PubMed ID: 26777134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human iPSC-Derived Neural Models for Studying Alzheimer's Disease: from Neural Stem Cells to Cerebral Organoids.
    Barak M; Fedorova V; Pospisilova V; Raska J; Vochyanova S; Sedmik J; Hribkova H; Klimova H; Vanova T; Bohaciakova D
    Stem Cell Rev Rep; 2022 Feb; 18(2):792-820. PubMed ID: 35107767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Important advances in Alzheimer's disease from the use of induced pluripotent stem cells.
    Majolo F; Marinowic DR; Machado DC; Da Costa JC
    J Biomed Sci; 2019 Feb; 26(1):15. PubMed ID: 30728025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology in the comorbidity of Bipolar Disorder and Alzheimer's Disease: pharmacological and stem cell approaches.
    Corrêa-Velloso JC; Gonçalves MC; Naaldijk Y; Oliveira-Giacomelli Á; Pillat MM; Ulrich H
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt A):34-53. PubMed ID: 28476640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease Modeling of Neuropsychiatric Brain Disorders Using Human Stem Cell-Based Neural Models.
    Kaindl J; Winner B
    Curr Top Behav Neurosci; 2019; 42():159-183. PubMed ID: 31407242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cells: a new tool to confront the challenge of neuropsychiatric disorders.
    Vaccarino FM; Stevens HE; Kocabas A; Palejev D; Szekely A; Grigorenko EL; Weissman S
    Neuropharmacology; 2011 Jun; 60(7-8):1355-63. PubMed ID: 21371482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.